×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Biotech bankruptcies hit 10-year peak in 2023
Fierce Biotech
More biotechs filed for bankruptcy in 2023 than any year since 2010, underscoring a brutal year defined by layoffs, company closures and...
3 months ago
Why Is OncoSec Medical (ONCS) Stock Down 48% Today?
InvestorPlace
Why Is OncoSec Medical (ONCS) Stock Down 48% Today? · OncoSec Medical (ONCS) is plummeting on bankruptcy news. · The company filed for...
11 months ago
OncoSec Announces Closing of $1.33 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
PR Newswire
PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company developing...
11 months ago
OncoSec Could Revolutionize Oncology Therapy
Medical Device and Diagnostic industry
A company known as OncoSec Medical Inc. (San Diego, CA) is working to become a trailblazer in the domain of medical electroporation technology. The firm is...
5 months ago
OncoSec Medical (OTCPK:ONCS.Q) - Stock Price, News & Analysis
Simply Wall Street
Research OncoSec Medical's (OTCPK:ONCS.Q) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and...
10 months ago
OncoSec R&D Facility and Lab Goes to Auction on Aug. 10
PR Newswire
PRNewswire/ -- By order of a U.S. bankruptcy court, Tiger Group and Liquidity Services on Aug. 10 will auction OncoSec Medical Inc.'s former...
9 months ago
Why Is OncoSec Medical (ONCS) Stock Up 100% Today?
InvestorPlace
OncoSec Medical (ONCS) stock is taking off on Friday after the company received a delisting notice that it doesn't intend to appeal.
10 months ago
OncoSec faces setback as blinded review reverses early impression, revealing Keytruda combo study flop
Fierce Biotech
OncoSec Medical's six-year pursuit of potentially pivotal data on its Keytruda combination has delivered a last-minute twist.
13 months ago
OncoSec is encouraged after FDA meeting to discuss proposed neoadjuvant melanoma clinical program
PR Newswire
PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the Company or OncoSec), a clinical-stage biotechnology company developing...
12 months ago
OncoSec Announces Reverse Stock Split
PR Newswire
PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ: ONCS) (the "Company" or "OncoSec"), a clinical-stage biotechnology company focused on...
18 months ago